KRAS G13D peptide, 25 mer

Modify Date: 2025-09-18 12:31:21

KRAS G13D peptide, 25 mer structure	Common Name	KRAS G13D peptide, 25 mer
	CAS Number	145019-94-9	Molecular Weight	2634.10
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₁₈H₂₀₁N₂₉O₃₆S	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of KRAS G13D peptide, 25 mer

KRAS G13D peptide, 25 mer, a KRAS activating oncogene mutation peptide, is an immune potentiator extracted from patent WO2018144775A1. KRAS G13D peptide, 25 mer can be used to prepare KRAS vaccine[1].

Name	KRAS G13D peptide, 25 mer

Description	KRAS G13D peptide, 25 mer, a KRAS activating oncogene mutation peptide, is an immune potentiator extracted from patent WO2018144775A1. KRAS G13D peptide, 25 mer can be used to prepare KRAS vaccine[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others Research Areas >> Inflammation/Immunology
In Vitro	KRAS G13D peptide, 25 mer is encoded by immunomodulatory therapeutic mRNA that can be used to prepare KRAS vaccine[1].
References	[1]. Huang EYC, et, al. Immunomodulatory therapeutic mrna compositions encoding activating oncogene mutation peptides. WO2018144775A1.

Molecular Formula	C₁₁₈H₂₀₁N₂₉O₃₆S
Molecular Weight	2634.10

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Palmitic acid
Price: Check
Purity: 98.0%
Delivery: 10 Day
Contact: Yang
Email: sales@echemcloud.com